PIK-293 is a PI3K inhibitor
For research use only. We do not sell to patients.
| Name | PIK-293 |
|---|---|
| Iupac Chemical Name | 2-((4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one |
| Synonyms | PIK-293; PIK 293 |
| Molecular Formula | C22H19N7O |
| Molecular Weight | 397.442 |
| Smile | NC1=C2C(=NC=N1)N(N=C2)CC2=NC1=CC=CC(=C1C(N2C2=C(C=CC=C2)C)=O)C |
| InChiKey | KQDBVHKNIYROHU-UHFFFAOYSA-N |
| InChi | InChI=1S/C22H19N7O/c1-13-6-3-4-9-17(13)29-18(27-16-8-5-7-14(2)19(16)22(29)30)11-28-21-15(10-26-28)20(23)24-12-25-21/h3-10,12H,11H2,1-2H3,(H2,23,24,25) |
| CAS Number | 900185-01-5 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |